Cover Image

Cognitive decline and carotid intima‐media thickness: The presumed association of two vaguely defined clinical “entities”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Christian Saleh
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Network‐based cortical atrophy predicts longitudinal clinical decline in sporadic behavioral variant frontotemporal dementia
by: Yuta Katsumi, et al.
Published: (2026)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
by: Sonja M. Kagerer, et al.
Published: (2024)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
by: Rosanne L. van den Berg, et al.
Published: (2025)

Hallucinations and delusions are associated with elevated tau PET signal independent of age, clinical severity, and amyloid burden
by: Aubrey S Johnson, et al.
Published: (2026)

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?
by: Giulia Giacomucci, et al.
Published: (2025)

Lower odor identification in subjective cognitive decline: a meta‐analysis
by: Benoît Jobin, et al.
Published: (2025)

Association of arterial structure and function with incident cardiovascular diseases and cognitive decline
by: Caroline Robert, et al.
Published: (2025)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
by: Ying Xia, et al.
Published: (2025)

Perceptions of cognitive decline among American Indian and Alaska Native elders
by: Cole Allick
Published: (2024)

Cardiometabolic disease, cognitive decline, and brain structure in middle and older age
by: Abigail Dove, et al.
Published: (2024)

Biomarkers of chronic inflammation and cognitive decline: A prospective observational study
by: Bhavna A. Guduguntla, et al.
Published: (2024)

Evaluation of two clinical Centiloid analysis products for 18F‐florbetapir PET in cognitively unimpaired elders
by: Frank P. DiFilippo, et al.
Published: (2025)

Sex variation in the relationship between APOE ε4, cognitive decline, and dementia
by: Eleanor M. Kerr, et al.
Published: (2025)

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
by: Frédéric Blanc, et al.
Published: (2025)

Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study
by: Kristine F. Moseholm, et al.
Published: (2024)

Corrections to “An explainable machine learning model of cognitive decline derived from speech”
Published: (2024)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
by: Stefan J. Teipel, et al.
Published: (2024)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
by: Talia Salzman, et al.
Published: (2025)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
by: Vicente Medel, et al.
Published: (2024)

Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive decline
by: Ismael L. Calandri, et al.
Published: (2024)

Incident traumatic experiences and poor financial well‐being: A double hit for cognitive decline?
by: Katrina L. Kezios, et al.
Published: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
by: Zheng Long Lee, et al.
Published: (2026)

Automated remote speech‐based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracy
by: Alexandra König, et al.
Published: (2024)

Procrastination as a marker of cognitive decline: Evidence from longitudinal transitions in the older adult population
by: Cormac Monaghan, et al.
Published: (2026)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
by: Carla R. Schubert, et al.
Published: (2024)

Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort
by: Micah J. Savin, et al.
Published: (2024)

Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease
by: R. Asaad Baksh, et al.
Published: (2024)

Underlying brain and genetic mechanisms linking historic phone use patterns, visual decline, and dementia risk in middle‐aged and older adults
by: Xiayin Zhang, et al.
Published: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
by: Emily K. Schworer, et al.
Published: (2024)

The Rapid Naming Test: Neuroanatomical validity and clinical utility
by: Kelly J. Atkins, et al.
Published: (2025)

Toward alpha‐synuclein seed amplification assay in clinical practice
by: Mathieu Verdurand, et al.
Published: (2025)

Reliability and validity of the Rhode Island Mobile Cognitive Assessment Tool
by: Laura E. Korthauer, et al.
Published: (2026)

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts
by: Tamao Tsukie, et al.
Published: (2025)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
by: Steffi De Meyer, et al.
Published: (2025)

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients
by: Els D. Bakker, et al.
Published: (2024)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
by: Willa D. Brenowitz, et al.
Published: (2026)

Speech and language features as indicators of neuropsychiatric symptoms in a memory clinic population
by: Zampeta‐Sofia Alexopoulou, et al.
Published: (2025)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
by: Robert Perneczky, et al.
Published: (2025)

Survey among experts on the future role of tau‐PET in clinical practice and trials
by: Marie R. Vermeiren, et al.
Published: (2024)